In a pragmatic trial of patients needing 2 or more weeks of IV antibiotics, early switch to oral had fewer adverse events than IV only (3.2% vs 6.5%, P=.02; HR 0.24) with equivalent efficacy; the trial stopped early, at two-thirds enrolment, for safety benefit.
RCT
Juskowich et al. Using the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics